Holen Sie sich die Stockscreener-App
12.94
1.07%
-0.14
Handel nachbörslich:
12.94
Schlusskurs vom Vortag:
$13.08
Offen:
$13.1
24-Stunden-Volumen:
1.21M
Relative Volume:
0.44
Marktkapitalisierung:
$1.47B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-284.08M
KGV:
-7.2697
EPS:
-1.78
Netto-Cashflow:
$-234.65M
1W Leistung:
+7.12%
1M Leistung:
+7.39%
6M Leistung:
+80.47%
1J Leistung:
+12.72%
1-Tages-Spanne:
$12.84
$13.23
1-Wochen-Bereich:
$11.87
$13.50
52-Wochen-Spanne:
$3.72
$13.50
Cogent Biosciences Inc Stock (COGT) Company Profile
Firmenname
Cogent Biosciences Inc
Sektor
Branche
Telefon
617-945-5576
Adresse
275 WYMAN STREET, WALTHAM
Vergleichen Sie COGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
12.94 | 1.68B | 0 | -284.08M | -234.65M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-11 | Herabstufung | Needham | Buy → Hold |
| 2024-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | Eingeleitet | Citigroup | Buy |
| 2023-12-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-12-08 | Eingeleitet | JP Morgan | Overweight |
| 2023-04-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-06-28 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-06-09 | Fortgesetzt | Jefferies | Buy |
| 2020-12-23 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Cogent Biosciences Inc Aktie (COGT) Neueste Nachrichten
Will breakout in Cogent Biosciences Inc. lead to full recoveryRate Hike & Technical Confirmation Trade Alerts - Newser
Cogent Biosciences Inc. stock daily chart insightsEarnings Miss & AI Driven Stock Price Forecasts - Newser
Technical analysis overview for Cogent Biosciences Inc. stockSell Signal & Reliable Price Action Trade Plans - Newser
Using economic indicators to assess Cogent Biosciences Inc. potentialWeekly Earnings Recap & Weekly Top Gainers Trade List - Newser
Live market analysis of Cogent Biosciences Inc.2025 Performance Recap & Consistent Income Trade Ideas - Newser
How sentiment analysis helps forecast Cogent Biosciences Inc.Buy Signal & Technical Pattern Based Signals - Newser
How to use Fibonacci retracement on Cogent Biosciences Inc.Quarterly Risk Review & Weekly Momentum Stock Picks - Newser
Real time alert setup for Cogent Biosciences Inc. performanceJuly 2025 Breakouts & Free Reliable Trade Execution Plans - Newser
Is Cogent Biosciences Inc. still worth holding after the dipWeekly Investment Summary & Technical Pattern Based Signals - Newser
Is Cogent Biosciences Inc. in a bullish channelLong Setup & Weekly Momentum Stock Picks - khodrobank.com
Volatility clustering patterns for Cogent Biosciences Inc.Weekly Gains Summary & Risk Adjusted Swing Trade Ideas - Newser
Combining price and volume data for Cogent Biosciences Inc.2025 Valuation Update & Long-Term Growth Stock Strategies - Newser
Using AI based signals to follow Cogent Biosciences Inc.Quarterly Portfolio Report & Real-Time Buy Zone Alerts - Newser
Cogent Biosciences’ Strategic Position in the Evolving Biopharma Landscape - AInvest
Transcript : Cogent Biosciences, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 09 - MarketScreener
Is Cogent Biosciences Inc. stock risky to hold nowQuarterly Risk Review & Verified High Yield Trade Plans - khodrobank.com
Cogent Biosciences stock hits 52-week high at 13.01 USD - Investing.com
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Benzinga
Is Cogent Biosciences Inc. forming a bullish divergenceGDP Growth & AI Enhanced Trade Execution Alerts - khodrobank.com
Raymond James Initiates Cogent Biosciences at Strong Buy - MarketScreener
Will Cogent Biosciences Inc. rebound enough to break evenJuly 2025 Decliners & Smart Investment Allocation Insights - Newser
What makes Cogent Biosciences Inc. stock price move sharplyJuly 2025 Trends & Risk Controlled Daily Trade Plans - Newser
Is it too late to sell Cogent Biosciences Inc.Long Setup & Accurate Buy Signal Alerts - Newser
Investment Report: Is Cogent Biosciences Inc. forming a bullish divergenceMarket Performance Summary & Stepwise Swing Trade Plans - khodrobank.com
Institutional scanner results for Cogent Biosciences Inc.Breakout Watch & Low Drawdown Momentum Ideas - Newser
How cyclical is Cogent Biosciences Inc.’s revenue streamQuarterly Earnings Report & Free Community Consensus Stock Picks - khodrobank.com
Developing predictive dashboards with Cogent Biosciences Inc. dataInflation Watch & Daily Oversold Bounce Ideas - Newser
What’s the recovery path for long term holders of Cogent Biosciences Inc.Earnings Recap Report & Capital Efficient Trade Techniques - Newser
Can Cogent Biosciences Inc. ride the EV wave2025 Growth vs Value & Weekly High Conviction Ideas - khodrobank.com
Trend Reversal Possible in Cogent Biosciences Inc. Charts Indicate getLinesFromResByArray error: size == 0 - 강소기업뉴스
Should you hold or exit Cogent Biosciences Inc. nowWeekly Trade Review & Long-Term Capital Growth Ideas - Newser
Using data filters to optimize entry into Cogent Biosciences Inc.2025 Institutional Moves & Verified Entry Point Signals - Newser
Signal strength of Cogent Biosciences Inc. stock in tech scannersWeekly Trade Report & Community Consensus Picks - Newser
Automated trading signals detected on Cogent Biosciences Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Cogent Biosciences Inc. Stock Flags Risk Zone in Volatility IndexEarnings Miss & Intraday High Probability Setup Alerts - beatles.ru
Reversal Traders Monitor Cogent Biosciences Inc. for Entry getLinesFromResByArray error: size == 0 - 더경남뉴스
Reversal indicators forming on Cogent Biosciences Inc. stockJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
How to use a screener to detect Cogent Biosciences Inc. breakoutsPortfolio Growth Summary & AI Driven Stock Reports - Newser
What to expect from Cogent Biosciences Inc. in the next 30 daysWeekly Investment Report & Fast Entry Momentum Alerts - Newser
Analyzing recovery setups for Cogent Biosciences Inc. investors2025 Investor Takeaways & Real-Time Sentiment Analysis - Newser
Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cogent Biosciences Inc-Aktie (COGT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Pinnow Cole | Chief Commercial Officer |
Jan 14 '25 |
Buy |
7.60 |
43,750 |
332,412 |
45,848 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):